Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Envisagenics logo

Envisagenics

Recent Finacing

Series B

Recent Raise

$25M

Envisagenics is a New York biotech using AI, machine learning and high-performance computing via its SpliceCore platform to analyze exon-centric RNA splicing and discover therapeutics for splicing-driven diseases.

Founded 2014
New York, United States
11-50
Private
envisagenics.com

Highlights

Focus Areas

Artificial Intelligence (AI)
Bioinformatics
Biotechnology
Machine Learning
Therapeutics

Recent Investors

New York Ventures logo
Third Kind Venture Capital logo
Dynamk Capital logo
Madrona Venture Group logo
C
Dolby Family Ventures logo
SV Angel logo
M12 logo
Notion Capital logo
Vertex Ventures logo
Red Cell Partners logo
Microsoft logo

Financials

$28.3M

Total Raised

4

Funding rounds

12

Investors


Team

Upgrade to view the team

See the team members at Envisagenics.